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ABSTRACT 
 
The key concepts (calibration, discrimination, and discordance) important in understanding and 
comparing risk models are best conveyed graphically.   To illustrate this, models predicting death and 
acute kidney injury in a large cohort of PCI patients differing in the number of predictors included are 
presented.  Calibration plots, often presented in the current literature, present the agreement between 
predicted and observed risk for deciles of risk.  Risk distribution curves present the frequency of 
different levels of risk.   Scatterplots of the risks assigned to individuals by different models show the 
discordance of the individual risk estimates.  Increasing the number of predictors in these models 
produce increasingly disperse and progressively skewed risk distribution curves.  These resemble the 
lognormal distributions expected when risk predictors interact multiplicatively.  These changes in the 
risk distribution curves correlate with improved measures of discrimination. 
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INTRODUCTION 
Clinicians are frequently challenged to interpret the literature on risk models and risk factors. A major 
reason is that publications on predictive models have largely focused on numerical presentations of 
their development and/or comparison.  And the experts may disagree on what numerical measures 
should be used, what they mean, and their clinical significance.1 
Calibration curves, scatterplots that compare predicted and observed risk in each decile of risk, are often 
presented.  Recently the value of graphical presentations of risk distribution curves or predictiveness 
curves has been emphasized. 2,3  The former is a graph of the frequency of risk versus risk and the latter 
a graph of risk versus the cumulative frequency of risk. Pepe,  Gu, and Morris have written that 
“Displaying risk distributions is a fundamental step in evaluating the performance of a risk prediction 
model, a step that is often overlooked in practice.”4  Another graphical presentation, a scatterplot 
presenting the discordance of individual risk estimates when two models are compared, was introduced 
by Lemeshow et al.5 and has recently been rediscovered by Pencina et al.6 
In this paper we use these graphical presentations to characterize models differing in the number of risk 
factors providing insights not available from numerical presentations.   
 
 
 
  
METHODS 
The study cohort for our analysis included patients undergoing Percutaneous Coronary Intervention 
(PCI) in years 2007 and 2008 in a large regional registry of contemporary PCI.  The details of the Blue 
Cross Blue Shield of Michigan Cardiovascular Consortium registry (BMC02) and of the data collection 
process have been described elsewhere.7, 8, 9, 10  Briefly procedural data on all patients undergoing 
elective and non-elective PCI at the 31 participating hospitals is collected using standardized data 
collection forms.  Baseline data include clinical, demographic, procedural, and angiographic 
characteristics as well as medications used before, during, and after the procedure, and in-hospital 
outcome.  All data elements have been prospectively defined and the local institutional review board at 
each institution approved the protocol.  The data is collected by a dedicated staff member and 
forwarded to the coordinating center.  Medical records of all patients undergoing coronary artery 
bypass grafting (CABG), and of patients who died in the hospital are reviewed by auditors from the 
coordinating center to ensure data accuracy.  A further 2% of cases are randomly selected for audit. 
Two outcomes were considered:   all-cause in-hospital death (death) and acute kidney injury (AKI).  AKI 
is an in-hospital outcome defined as “peak minus baseline creatinine ≥0.5 mg/dL”, with peak creatinine 
measured in-hospital before discharge. Death was less common (1.10%) than AKI (3.40%).   
 Of the total cohort, 60,654 patients were included in the death model while 47,775 patients were 
included in the AKI model.  Of the 13,209 patients who were not included in the AKI model, 1238 were 
on dialysis prior to the procedure while 10595 patients were excluded due to absence of serum 
creatinine before or after the procedure  and 1756 were excluded due to absence of body weight. 
We developed a series of models for death and AKI strictly for illustrative purposes.  Our goal was to 
show the effect of increasing numbers of predictors on the risk distribution curve and associated 
measures.  Full models (model 5) for death and AKI were developed by ascending stepwise logistic 
regression.  Then a series of nested submodels (models 1, 2, 3, and 4) with increasing numbers of 
predictors were constructed for death and AKI.  Model 1 had only had age and gender.  Subsequently 
additional predictors were added to generate models 2, 3, and 4, with the strongest predictors added 
first.  Predictors were categorical variables, with the exception of baseline creatinine in the AKI models.  
The predictors in the death model were limited to those available prior to PCI, while the predictors in 
the AKI model also included procedural and angiographic data.  
Statistical support for this project was constrained by time, so additional analyses and/or alternative 
graphics could not be generated. 
RESULTS 
Tables 1 and 2 summarize the 5 models for death and AKI, respectively.  As more predictors are included 
in the models, measures of goodness of fit and discrimination are progressively improved. Cardiogenic 
shock was the strongest predictor for death and AKI. 
For death, although model 1 has a significant Hosmer-Lemshow statistic, the other models are 
calibrated by this metric.  Figure 1 shows the calibration plots lie near the line of identify for the 5 death 
models, which supports the calibration of the models.  For AKI, however, all but model 1 have significant 
Hosmer-Lemeshow statistics.  Again, the calibration plots in figure 2 support the calibration of the 
models.  Significant Hosmer-Lemeshow tests with small departures from a proposed model with large 
data sets is well recognized.11 
Figures 3 and 4 present the risk distribution curves for the 5 models for death and AKI, respectively.  
Even model 1 with only age and gender produces distributions with substantial dispersion around the 
mean risks.  (for death:  668 in 60,656 subjects=0.011013, for AKI 1615 in 47,446 subjects without 
missing data=0.034039)  As additional predictors are added, the curves become increasingly disperse.  In 
addition the curves become increasingly skewed. 
More disperse risk distribution curves assign fewer cases to the 1stand more cases to the 10th decile, 
reflecting their improved discrimination.   Of the 668 deaths, the number of cases in the 1st decile/10th 
decile were 35/183, 6/472, 3/460, 2/506, and 3/510 in models 1, 2, 3, 4, and 5, respectively.  Of the 
1615 cases of AKI, the number of cases in the 1st decile/10th decile were 64/290, 27/752, 24/780, 
23/838, and 22/849 in models 1, 2, 3, 4, and 5, respectively.   
Numerical tables, calibration plots, and risk distribution curves describe how addition of predictors 
improves the risk stratification of the population, but not their effects on individuals.   This is best 
appreciated by inspecting a scatterplots of the individual risk estimates from two models.  Figures 5 and 
6 do this for models 4 and 5 for death and AKI, respectively.  These two models were the closest in 
terms of risk stratification of the population, but clearly give different results at the individual level. 
In theory, risk distribution curves generated from multiple risk factors that interact multiplicatively 
should be lognormal.12 In figure 7 simulated lognormal risk distribution curves with mean risks of 0.011 
and 0.034, the mean risks of death and AKI, respectively, but differing dispersion are presented for 
comparison to the risk distribution curves of figures 3 and 4.  Curves with low dispersion are 
symmetrical and centered on the mean.  Curves with higher dispersion are progressively skewed to the 
right.    
 
 DISCUSSION 
We agree with Jaynes, who wrote “The First Commandment of scientific data analysis publication ought 
to be: 'Thou shalt reveal thy full original data, unmutilated by any processing whatsoever.”13 Before 
calculating statistics, especially on categorized data, readers should be given an opportunity to visualize 
the data. 
Numerical results do not provide the insight provided by risk distribution curves.  The latter present the 
location, dispersion, and shape of the risk distribution curve.  Comparison of risk distributions differing 
in the number of predictors allows a better understanding of the modeling process. 
Nomenclature is confusing as both calibration and discrimination are referred to as accuracy.  However 
they are completely different conceptually.  Calibration refers to the agreement between predictions 
and observations.  But even a model with no predictors can have perfect calibration.  Such a model 
would assign everyone the mean risk and, if the observed risk in the population matched this prediction, 
then the model would be perfectly calibrated.  Addition of risk factors to a model should not alter the 
agreement between observations and predictions.  Thus accuracy, defined as calibration, is not a 
function of the number of predictors in a model.  Calibration plots presenting observed versus predicted 
risk for each decile of risk allow for a graphical evaluation of the agreement.   
Although additional risk factors do not provide improved calibration or accuracy, they do provide 
improved discrimination.  This is measured by the c-statistic or area under the ROC curve, which are 
measures of the overlap between the risk distribution curves for cases and controls, both of which are 
fully determined by the population risk distribution.   Improved discrimination reflects the dispersion of 
the risk distribution curve.  Narrow risk distribution curves assign patients who will have events and 
those who won’t have events similar probabilities of an outcome.  In this instance there must be 
substantial overlap of the derived risk distribution curves for cases and controls.  On the other hand, as 
additional risk factors are included, broader risk distribution curves result in cases and controls being 
assigned increasingly different probabilities of an outcome.  This is readily appreciated when a 
composite plot of risk distribution curves generated by models differing in the number of predictors is 
presented. 
Presenting risk distribution curves separately for cases and controls has been advocated.14 We agree this 
well depicts the discrimination of the two groups.  However we favor the population risk distribution 
curve as, in theory, the risk distribution curves for cases and controls can be calculated directly from the 
risk distribution curve for the population.15 
An additional feature apparent from the composite plot is that the distributions also become 
increasingly asymmetric as additional predictors are included.  When a sufficient number of risk factors 
interact multiplicatively, the expected distribution of risk in the population is lognormal.12 We suggest 
that that is the case with this series of models.  Narrow lognormal curves are symmetric and resemble 
normal distributions.  But increasing dispersion is associated with increasingly asymmetric lognormal 
curves.  That simulated lognormal curves with the same mean risks as observed for death and AKI 
appear similar supports the suggestion of lognormality.   
But even the addition of risk distribution curves to numerical presentations provides no insight into how 
individuals are characterized by different models.  This is best appreciated from a scatterplot of the 
calculated risks for individuals derived from two models, an approach introduced by Lemeshow et al.   
When models are nested, as is the case here, this discordance may be less than when there are fewer 
shared predictors.  Nonetheless, even when addition of predictors has little or no impact on the 
dispersion of the risk distribution curve, there can be significant disagreement.  When the risk 
distribution is split into categories, disagreement has been termed reclassification.  However when the 
models are calibrated and their risk distributions are similar, this reclassification has little clinical 
significance. 
The presentation and understanding of risk models would be improved by including risk distribution 
curves in all publications.  Graphical presentation of the data prior to categorization and/or statistical 
analysis is standard practice in other areas of science and medicine.  Risk distribution curves directly 
depict the dispersion of the risks assigned by a model.  That measures of discrimination reflect this 
dispersion is an important point that has been overlooked because of the lack of graphical presentation.  
When more than one model is utilized, comparison of risk distribution curves allow the observer to 
assess whether they differ in location (demonstrating a difference in calibration) or dispersion 
(demonstrating a difference in discrimination).  Since risk distribution curves are not presented, there 
has been no attention paid to their shape and the influence of increasing the number of included 
predictors on their shape.  A normal distribution cannot be assumed and the skewing of distributions 
would be important information for modeling the clinical benefit of adding additional predictors to a 
model 
Scatterplots of the predicted risk for individuals from two models, originally proposed by Lemeshow et 
al.5 and more recently suggested by Pencina et al.,6 should also be presented in publications.  As for risk 
distribution curves, this should precede categorization and/or statistical analysis.      
The clinical goal of model development is to identify risk factors that produce optimal population risk 
stratification, which means identification of subpopulations that are as large as possible and differ as 
much as possible from each other and that are calibrated.  Intuitively, this should correspond to a risk 
distribution curve as disperse as possible.   
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Table 1 
DEATH MODELS 
 
 MODEL 1 MODEL 2 MODEL 3 MODEL 4 MODEL 5 
C statistic 0.662 0.883 0.901 0.912 0.921 
H-L statistic 0.0004 0.1976 0.0981 0.1771 0.1800 
AIC 7128 5296 5139 4943 4861 
 EST OR EST OR EST OR EST OR EST OR 
Intercept -7.8939  -9.9657  -10.2236  -10.3139  -10.1431  
Gender 0.1179 1.125 0.1010 1.106 0.1934 1.213 0.2964 1.345 0.2579 1.294 
Age 0.0494 1.051 0.0580 1.060 0.0545 1.056 0.0526 1.054 0.0442 1.045 
Shock/MI   2.5382 12.656 2.3521 10.507 1.9117 6.764 1.8664 6.465 
MI   1.8468 6.339 1.5433 4.680 0.9864 2.682 0.9682 2.633 
Arrest   1.6206 5.056 1.5201 4.573 1.4194 4.135 1.4342 4.196 
LVEF<50     1.2130 3.364 1.0734 2.925 0.9693 2.636 
Crt>2       1.270 3.561 0.9486 2.582 
Crt 1.5-2       0.7717 2.163 0.6504 1.916 
Emergency PCI       1.1210 3.068 1.3090 3.702 
Valve disease         0.6580 1.931 
Anemia         0.5643 1.758 
PVD/CVA         0.3599 1.433 
Hx CHF         0.1923 1.212 
           
           
 
Table 2 
AKI MODELS 
 MODEL 1 MODEL 2 MODEL 3 MODEL 4 MODEL 5 
C-statistic 0.645 0.797 0.812 0.832 0.836 
HL statistic 0.8284 0.0016 0.0209 0.001 0.0154 
AIC 13680 12046 11806 11458 11361 
 EST OR EST OR EST OR EST OR EST OR 
Intercept -6.1013  -7.8511  -7.079  -7.8573  -7.5164  
Gender 0.3207 1.378 0.37370 1.452 0.3553 1.427 0.3689 1.446 0.2493 1.283 
Age 0.0391 1.040 0.0385 1.039 0.0332 1.034 0.0278 1.028 0.0181 1.018 
Shock/MI   1.8004 6.052 1.5306 4.621 1.4151 4.117 1.2439 3.469 
MI   1.1698 3.221 0.8854 2.424 0.7995 2.224 0.7226 2.060 
DM   0.8698 2.386 0.7935 2.211 0.6121 1.844 0.6193 1.858 
Pre Crt   0.6147 1.849 0.5340 1.706 0.4656 1.593 0.3205 1.378 
Anemia     0.7977 2.220 0.6478 1.911 0.614 1.849 
Emergency PCI     0.6585 1.932 0.7243 2.063 0.6020 1.826 
Valve disease       0.5455 1.725 0.5280 1.696 
LVEF<50       0.5356 1.708 0.5285 1.696 
Hx CHF       0.5294 1.698 0.5041 1.655 
PVD/CVA       0.4384 1.550 0.4198 1.522 
Obese       0.2962 1.345 0.4694 1.599 
Overweight       0.1319 1.141 0.2295 1.258 
Crt Cl 1-30         0.8138 2.2257 
Crt Cl 30-59         0.5240 1.689 
Crt Cl 60-89         0.3399 1.405 
Cardiac arrest         0.4089 1.505 
Stenosis 70         0.3880 1.474 
COPD         0.2790 1.322 
Thrombus         0.2558 1.291 
Vess dis 70         0.2050 1.227 
H HYP         0.1735 1.190 
Calcification         0.1409 1.151 
Hx PTCA         -0.1761 0.839 
CABG         -0.3970 0.672 
 
 
FIGURES 
Figure 1.  Death Calibration Plots.   
 Model 1, orange; model 2, blue; model 3, green; model 4, red; and model 5, black 
Figure 2.  AKI Calibration Plots 
 Model 1, orange; model 2, blue; model 3, green; model 4, red; and model 5, black 
Figure 3.  Death Risk Distribution Curves 
 Model 1, orange; model 2, blue; model 3, green; model 4, red; and model 5, black 
Figure 4.  AKI Risk Distribution Curves 
 Model 1, orange; model 2, blue; model 3, green; model 4, red; and model 5, black 
Figure 5.  Death Discordance Plot for Model 4 versus Model 5 
Figure 6.  AKI Discordance Plot for Model 4 versus Model 5 
Figure 7.  Simulated Lognormal Risk Distribution Curves 
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FIGURE 7 
 
 
 
 
 
Simulated Lognormal Risk Distribution Curves with Mean Risks of 0.011 (above) and 0.034 (below)  
